Cingulate Stock Analysis

Cingulate Stock Analysis Notes

The company has price-to-book (P/B) ratio of 1.1. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cingulate recorded a loss per share of 45.06. The entity had not issued any dividends in recent years. The firm had 1:12 split on the 9th of August 2024. Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficithyperactivity disorder. The company was founded in 2012 and is headquartered in Kansas City, Kansas. Cingulate operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people. For more info on Cingulate please contact Shane PharmD at 913 942 2300 or go to https://www.cingulate.com.

Cingulate Investment Alerts

Cingulate Upcoming and Recent Events

Cingulate Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.86 M.

Technical Drivers

As of the 20th of March, Cingulate shows the Mean Deviation of 2.95, insignificant risk adjusted performance, and Standard Deviation of 4.05. Cingulate technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Cingulate variance and value at risk to decide if Cingulate is priced correctly, providing market reflects its regular price of 3.8 per share. Given that Cingulate has information ratio of 0.0041, we suggest you to validate Cingulate's prevailing market performance to make sure the company can sustain itself at a future point.

Cingulate Price Movement Analysis

Cingulate Insider Trading Activities

Cingulate Outstanding Bonds

Cingulate Predictive Daily Indicators

Cingulate Forecast Models

Cingulate's time-series forecasting models are one of many Cingulate's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cingulate's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Cingulate prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cingulate shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cingulate. By using and applying Cingulate Stock analysis, traders can create a robust methodology for identifying Cingulate entry and exit points for their positions.

When running Cingulate's price analysis, check to measure Cingulate's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cingulate is operating at the current time. Most of Cingulate's value examination focuses on studying past and present price action to predict the probability of Cingulate's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cingulate's price. Additionally, you may evaluate how the addition of Cingulate to your portfolios can decrease your overall portfolio volatility.